Bruck Pharma Private Limited
Indian Pharmaceutical Exporter ยท Immunosuppressants Specialist ยท $73.5K Total Trade ยท DGFT Verified
Bruck Pharma Private Limited is an Indian pharmaceutical exporter with a total trade value of $73.5K across 5 products in 3 therapeutic categories. Based on 28 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Everolimus ($33.7K), Busulfan ($19.1K), Vinblastine ($13.0K).
Bruck Pharma Private Limited โ Export Portfolio & Destination Treemap

Who is Bruck Pharma Private Limited? โ Company Overview & Market Position
Bruck Pharma Private Limited, established on August 23, 1984, is a privately held pharmaceutical company headquartered in Goregaon East, Maharashtra, India. The company is registered under the Corporate Identification Number (CIN) U24239MH1984PTC416799. As of the latest available data, Bruck Pharma has an authorized capital of โน5.00 crore and a paid-up capital of โน2.68 crore.
The company specializes in the manufacturing and marketing of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Bruck Pharma focuses on providing high-quality medicines across various therapeutic segments, with a particular emphasis on oncology and immunosuppressants. Their product portfolio is designed to meet the needs of specialist physicians and patients globally.